These randomized results are encouraging, although the field awaits longer-term data to see how the leads hold up.

Physiologic pacing of the His-Purkinje conduction system is feasible in patients who require a permanent pacemaker following TAVR and this alternative pacing method did not interfere with ejection ...

Conduction system pacing got a class IIb recommendation for patients needing permanent pacing who have left ventricular ejection fraction (LVEF) of 36-50% but are not expected to require ...

NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF ...

Conduction system pacing, or CSP as we call it, includes pacing the His bundle or the left bundle branch. Left bundle-branch pacing has now largely replaced His-bundle pacing.

Professor Michael Glikson, Co-chair of the ESC Clinical Consensus Statement and the 2021 ESC Guidelines, stated, "Conduction system pacing is a big step forward in the pacing world.

Boston Scientific announced it received FDA approval to expand the indication for its pacing leads to include conduction system pacing of the left bundle branch area when connected to a single- or ...

Abbott's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...

Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates DUBLIN, Oct. 17, 2022 ...

But one of the limitations to current leadless pacemakers is they are limited to ventricular pacing in the [right ventricle] and they cannot perform conduction system pacing or left bundle branch ...

Abbott (NYSE: ABT) today announced late-breaking data from the AVEIR™ Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the ...

Medtronic is the first and only company with therapies approved for conduction system pacing. In 2018, the FDA approved the SelectSecure™ MRI SureScan® Model 3830 cardiac lead for His-Bundle ...